INNT
TOTAL INVALIDATION PROCESSED BY THE IB
09/14/2024
Back to search
Official data from USPTO
PCAS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
09/14/2024
Trademark type
Combined
Nice classes
1, 4, 5, 42
Filing date
01/28/2016
Registration date
05/30/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/15/2023
Last transaction
12/15/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
FR
Examiner
SMITH, REBECCA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a logotype representing a sequence of stylized DNA (symbolizing the life sciences) central axis composed of two dark blue quadrilaterals (symbolizing chemical structures) on either side of a larger transverse, light blue shape with broken lines. To the right of this logotype are the stylized letters "PCAS" in light blue.
Holders and representatives
Holders
PCAS
P. S. (pessoa física)
Representatives
MAURICE B. PILOSOF MAURICE B. PILOSOF, ESQ
Technical classification
Nice Classes
Class 1Class 4Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products for use in industrysciencephotographyas well as in agriculturehorticulture and forestry; chemical preparations for solderingadhesive substances for industrial use; unprocessed artificial resinsunprocessed plastics; chemical reagents other than for medical or veterinary use
Class 4
Industrial oils and greaseslubricants
Class 5
Pharmaceuticalveterinary and sanitary products for medical purposessynthesis intermediates and active ingredients used in the manufacture of medicinalactive pharmaceutical ingredients (APIs)additives and chemical intermediatesantimicrobial preparations for preventing bacteria; pharmaceutical and medicinal preparations and substancesbacteriostatsantibioticsmedicinal preparations for the treatment of infectious diseasesmedicinal herbal extracts for medical purposes; Pharmaceutical productsActive Pharmaceutical ingredients (API's) for human and veterinary use; medicalbiologicalbiotechnologicalproteinvirologicalimmunologicalbacteriologicalchemicalenzymatic and products for medical and veterinary usemixed biological preparations for the prevention and treatment of infectious diseasescomplex molecules for life science and innovative technologiesbacteriological preparationschemical reagents; diagnostic preparations for medicalpharmaceutical and veterinary use; cellmicroorganism or virus cultures for medical and veterinary use; adjuvants for medical or veterinary use; antibioticspharmaceutical preparations for medical and veterinary usenucleic acidsproteinsrecombinant proteinspeptidespeptide antigensblood serumfor medicalpharmaceutical and veterinary use; biological products and preparations for medical usemedicinediagnostic reagents made from humananimal and microorganismfor the preventiondiagnosis or treatment of diseases and cellular veterinary products and preparationsfor use in biotechnologyparticularly for production of recombinant proteinsmonoclonal antibodiesfor biomedical diagnosticprophylactictherapeutic and clinical applicationexcipients; proteins arrays for medical or veterinary use; micro-organisms for medical usebacteriaalgaeincluding cell linescell cultures and cell expression systems from mammals used for biomolecule production
Class 42
Scientific research; industrial research in the field of chemistrybiochemistryenzymologybiologymicrobiologycell biologypharmaceuticalsbiotechnology; research and development of new products for others; biological research; technical research in the field of chemistrybiochemistryenzymologybiologymicrobiologycell biologypharmaceuticalsbiotechnology and technical research for others relating to medical devices and pharmaceuticals in the field of veterinary
Publications
History of USPTO decisions and trademark events.
44 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/28/2024
INPC
INVALIDATION PROCESSED
08/28/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/16/2024
C71T
CANCELLED SECTION 71
12/15/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/30/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/28/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/07/2017
FIMP
FINAL DISPOSITION PROCESSED
09/07/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/30/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/11/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/30/2017
GPNX
NOTIFICATION PROCESSED BY IB
04/08/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/23/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2017
PUBO
PUBLISHED FOR OPPOSITION
03/14/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/22/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/22/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/04/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/24/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
01/24/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/24/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
01/24/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/24/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/23/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
01/17/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/17/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
01/17/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/17/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/14/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/14/2017
ALIE
ASSIGNED TO LIE
01/13/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2016
RFNT
REFUSAL PROCESSED BY IB
07/02/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/15/2016
RFRR
REFUSAL PROCESSED BY MPU
06/15/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/15/2016
CNRT
NON-FINAL ACTION WRITTEN
06/14/2016
MAFR
APPLICATION FILING RECEIPT MAILED
06/14/2016
DOCK
ASSIGNED TO EXAMINER
06/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/02/2016
Continuous trademark protection
Get notified about every new filing that threatens PCAS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.